Diagnostics Segment Leader/Marketing Leader Cell Analysis, Cytiva
Diagnostics Segment Leader/Marketing Leader Cell Analysis, Cytiva
Professor, Pathology and Laboratory Medicine, Center for Immunology and Infectious Disease and UC Davis Comprehensive Cancer Center
PhD in Neuroimmunology from the University of Tübingen, Germany, Manager Immunology Screening Services at Horizon Discovery
Assistant Professor, University of Pittsburgh, Hillman Cancer Center
Application Scientist - Advanced Cell Diagnostics
Technology Manager for Biosciences, GE Research Center
President, The Histochemical Society; Science Director for Cytiva
Professor Emeritus of Pathology, University of Arizona; Founder and Chief Scientific Advisor Emeritus, Ventana Medical Systems, Inc., a division of Roche
Director of the Melanoma Center and the Center for Immuno-Oncology, Dana-Farber Cancer Institute, Professor of Medicine, Harvard Medical School
Application Development Engineer
Senior Research Investigator II, Leads Discovery & Optimization, Bristol Myers Squibb, Princeton, NJ, USA
Postdoctoral Fellow, Laboratory of Dr. Philip Greenberg, Fred Hutchinson Cancer Research Center, Scholar of the Parker Institute for Cancer Immunotherapy
Assistant Research Physician, National Institutes of Health, National Cancer Institute, Genitourinary Malignancy Branch and the Laboratory of Tumor Immunology and Biology
Biomarkers & Cytometry Specialistm MilliporeSigma
Clinical Scientist, The Parker Institute for Cancer Immunotherapy, and Former Medical Oncology Fellow at the University of Texas MD Anderson Cancer Center
Principal Investigator, Seattle Children's Research Institute, Assistant Professor, University of Washington School of Medicine
Senior Scientist, MilliporeSigma
Physician scientist at NCI (National Cancer Institute)
Chief Scientific Officer, Scribe Biosciences
Assistant Professor, Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center
Product Manager of Neoantigen Peptide Services at GenScript
This event is now apart of the Cancer Research & Immuno-Oncology Week Virtual Event Series.
Labroots is pleased to announce the inauguration of the Immuno-Oncology Virtual Event Series taking place on June 3, 2020. Immuno-oncology is considered by some to be one of the most promising areas of research in the world of anti-cancer therapeutics. Learn from our experts how immunotherapies can work alone, together, or in combination with other treatments to fight cancer.
This years event will include the following tracks and topics:
Latest Trends in Immuno-Oncology
Immunotherapeutic Modalities
Development and Clinical Applications of Cancer Immunotherapies
Recent breakthroughs in immuno-oncology research translate into a paradigm shift with regards to attacking advancing cancer. The benefits of immuno-oncology have resulted in long-lasting tumor regression where surgery, radiotherapy, chemotherapy, and targeted therapy proved less effective.
Our virtual conference allows you to participate in a global setting with no travel or cost to you. The event will remain open 6 months from the date of the live event. The webinars will be available for unlimited on-demand viewing. This virtual conference also offers increased reach for the global microbiology community with a high degree of interaction through live-streaming video and chat sessions.
Like the 2019 conference, this event will be produced on our robust platform, allowing you to watch, learn and connect seamlessly across all desktop or mobile devices. Equipped with gamification and point system, you can now move around the entire event, earning points for a chance to win one of LabRoots' most popular T-shirts.
Call for Posters — Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Plan now to have your poster included in the 2020 Immuno-Oncology Virtual Event. Submission is free. Submit your abstract here.
Continuing Education
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this event, you can earn 1 Continuing Education credit per presentation for a maximum of 30 credits.
Use #LRimmuno to follow the conversation!
Akoya Biosciences' history represents the rapid advancement driving the field of multiplexed biomarker analysis and immunofluorescence tissue analysis. Today's Akoya portfolio spans the spectrum from powerful tools for discovery of important biomarkers to clinical research ...
See moreLeica Biosystems is a global leader in Anatomical Pathology solutions and automation, striving to advance cancer diagnostics to improve patients' lives. Leica Biosystems provides Pathologists, Histologists, and Researchers a comprehensive range of products for each step in the ...
See moreFor over 30 years, Miltenyi Biotec has been a leader in the development of products that empower the advancement of biomedical research and enable cell and gene therapy. We provide innovative tools to help with your sample preparation, cell isolation, cell culture, and cell ...
See moreHorizon Discovery Group PLC is a world leader in the utilization of gene editing and gene modulation technologies to support the greater understanding of gene function, the genetic drivers behind human disease and the development of molecular, cell and gene therapies to enable ...
See moreVisiopharm® is a world leader in Augmented Pathology™ solutions; that comprise precision pathology and high-throughput pathology for tissue-diagnostics and research. Leading biopharmaceutical companies, contract research organizations (CRO), academic medical centers, and ...
See moreOUR MISSION here at Indica Labs is to provide solutions that streamline the image analysis workflow for digital pathology, including HALO and HALO AI for fast, quantitative evaluation of images and HALO Link for collaborative image and data management. Our PHARMA SERVICES team ...
See moreACD shortens the path to personalized medicine by unlocking the power of RNA biomarkers. Advanced Cell Diagnostics, Inc. (ACD) is a leader in the emerging field of molecular pathology, developing cell- and tissue-based diagnostic tests for personalized medicine. Based in the ...
See moreExpertise in Automated Cell Counting and Analysis In 2003, the founders of Nexcelom introduced the CP2, a convenient tool to assist with manual cell counting. According to Dr. Jean Qiu, founder and CTO at Nexcelom, One day a customer at the NIH asked us to 'make counting ...
See moreRoche Diagnostics develops and produces medical tests and digital tools that provide information to help healthcare professionals find the right treatment for patients and deliver the best patient care to improve, prolong and save lives. Currently, Roche Diagnostics leads the ...
See moreLI-COR first introduced scientific instruments for plant science research and quickly grew to provide scientists tools for such diverse disciplines as atmospheric research and the study of how proteins interact at the cellular level. LI-COR Biosciences is a global leader in the ...
See moreSony Biotechnology Inc. is dedicated to helping researchers working across different life science disciplines to achieve the best scientific results. By leveraging Sony's vast know-how in electronics innovation and design we offer next-generation cell analysis systems to ...
See moreLunaphore is a Swiss firm born with the vision of bringing -omics like approaches to in-situ tissue analytics for cancer research and diagnostic purposes. Lunaphore develops innovative tissue staining platforms based on a cutting-edge technology, providing high quality results ...
See moreUltivue provides researchers and scientists with multiplex biomarker assays for tissue phenotyping and digital pathology. Ultivue's InSituPlex® technology eliminates the need for assay development and enables scientists to unmask and analyze the true biological context of tissue ...
See moreOriGene Technologies was founded as a research tool company focused on the creation of the large commercial collection of full-length human cDNAs in a standard expression vector. The availability of the complete human genome sequence and the subsequent development of genome-based ...
See moreYou need to conduct assay development or drug screening for cancer research using biologically relevant cell models. Molecular Devices complete imaging solutions can help you achieve your goals. Our imaging cytometry platform offers visual confidence and cell-by-cell statistics ...
See moreManuscriptedit specializes in providing services in Scientific & English editing, proofreading, medical writing, academic writing, formatting and publication support. Within a short span of time, the company has grown rapidly to be counted among the world's leading service ...
See moreThe Sartorius Group is a leading international partner of biopharmaceutical research and the industry. With innovative laboratory instruments and consumables, the Group's Lab Products & Services Division concentrates on serving the needs of laboratories performing research and ...
See moreOur purpose is to solve the toughest problems in life science by collaborating with the global scientific community - and through that, we aim to accelerate access to better health for people everywhere.
PerkinElmer is working closely with laboratories around the world to deliver the nucleic acid isolation, automation, real-time PCR, antibody testing, and NGS library preparation solutions they need to rapidly respond to the SARS-CoV-2 challenges both today and tomorrow. To ...
See moreSony Biotechnology Inc. is dedicated to helping researchers working across different life science disciplines to achieve the best scientific results. By leveraging Sony's vast know-how in electronics innovation and design we offer next-generation cell analysis systems to ...
See more